Literature DB >> 8497066

RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

D Riley1, S J Flint.   

Abstract

The adenovirus L4 100-kDa nonstructural protein (100K protein) is required for efficient initiation of translation of viral late mRNA species during the late mRNA species during the late phase of infection (B. W. Hayes, G. C. Telling, M. M. Myat, J. F. Williams, and S. J. Flint, J. Virol. 64:2732-2742, 1990). The RNA-binding properties of this protein were analyzed in an immunoprecipitation assay with the 100K-specific monoclonal antibody 2100K-1 (C. L. Cepko and P. A. Sharp, Virology 129:137-154, 1983). Coprecipitation of the 100K protein and 3H-infected cell RNA was demonstrated. The RNA-binding activity of the 100K protein was inhibited by single-stranded DNA but not by double-stranded DNA, double-stranded RNA, or tRNA. Competition assays were used to investigate the specificity with which the 100K protein binds to RNA in vitro. Although the protein exhibited a strong preference for the ribohomopolymer poly(U) or poly(G), no specific binding to viral mRNA species could be detected; uninfected or adenovirus type 5-infected HeLa cell poly(A)-containing and poly(A)-lacking RNAs were all effective inhibitors of binding of the protein to viral late mRNA. Similar results were obtained when the binding of the 100K protein to a single, in vitro-synthesized L2 mRNA was assessed. The poly(U)-binding activity of the 100K protein was used to compare the RNA-binding properties of the 100K protein prepared from cells infected by adenovirus type 5 and the H5ts1 mutant (B. W. Hayes, G. C. Telling, M. M. Myat, J. F. Williams, and S. J. Flint, J. Virol. 64:2732-2742, 1990). A temperature-dependent decrease in H5ts1 100K protein binding was observed, correlating with the impaired translational function of this protein in vivo. By contrast, wild-type 100K protein RNA binding was unaffected by temperature. These data suggest that the 100K protein acts to increase the translational efficiency of viral late mRNA species by a mechanism that involves binding to RNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497066      PMCID: PMC237706          DOI: 10.1128/JVI.67.6.3586-3595.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  The proteins associated with mRNA from uninfected and adenovirus type 5-infected KB cells.

Authors:  P Van der Marel; J G Tasseron-de Jong; L Bosch
Journal:  FEBS Lett       Date:  1975-03-01       Impact factor: 4.124

2.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

3.  Characterization of mRNA-protein complexes from mammalian cells.

Authors:  B Sundquist; T Persson; U Lindberg
Journal:  Nucleic Acids Res       Date:  1977-04       Impact factor: 16.971

4.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

5.  Isolation of temperature-sensitive mutants of adenovirus type 5.

Authors:  J F Williams; M Gharpure; S Ustacelebi; S McDonald
Journal:  J Gen Virol       Date:  1971-05       Impact factor: 3.891

6.  Isolation of messenger ribonucleoproteins from mammalian cells.

Authors:  U Lindberg; B Sundquist
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

7.  Phosphoproteins of adenovirus 2.

Authors:  N Axelrod
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

8.  Messenger ribonucleoprotein complexes in human KB cells infected with adenovirus type 5 contain tightly bound viral-coded '100K' proteins.

Authors:  J G Tasseron-De Jong; J Brouwer; K Rietveld; C E Zoetemelk; L Bosch
Journal:  Eur J Biochem       Date:  1979-10

9.  Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.

Authors:  J T Huang; R J Schneider
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

10.  Polypeptide phosphorylation in adenovirus-infected cells.

Authors:  W C Russell; G E Blair
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

View more
  20 in total

1.  Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F.

Authors:  R Cuesta; Q Xi; R J Schneider
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications.

Authors:  B L Hodges; H K Evans; R S Everett; E Y Ding; D Serra; A Amalfitano
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs.

Authors:  Qiaoran Xi; Rafael Cuesta; Robert J Schneider
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.

Authors:  W Huang; S J Flint
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  In vivo transcription from the adenovirus E2 early promoter by RNA polymerase III.

Authors:  W Huang; R Pruzan; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Protein arginine methylation during lytic adenovirus infection.

Authors:  Julia Kzhyshkowska; Elisabeth Kremmer; Markus Hofmann; Hans Wolf; Thomas Dobner
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

8.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting.

Authors:  Qiaoran Xi; Rafael Cuesta; Robert J Schneider
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

10.  A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.

Authors:  Felipe Andrade; Livia A Casciola-Rosen; Antony Rosen
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.